亚宝药业：目前在临床阶段的创新药研发项目

Core Viewpoint - The company, Yabao Pharmaceutical, is actively developing innovative drugs in clinical stages, focusing on various therapeutic areas [1] Group 1: Drug Development Projects - The company has a Class 1 innovative traditional Chinese medicine for treating insomnia, named Chaiqin Ningxin Granules, which is currently in Phase II clinical trials [1] - Another Class 1 innovative traditional Chinese medicine, ZY-A002, aimed at treating pediatric variant asthma, is in Phase III clinical trials [1] - The company is also developing a Class 1 biological new drug, SY-005, for treating sepsis and neurological damage after brain glioma surgery, which is in Phase II clinical trials [1]